Ligand Pharmaceuticals Valuation
| LGNZZ Stock | USD 0.11 0.01 10.00% |
Ligand Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Ligand Pharmaceuticals from analyzing the firm fundamentals such as Total Asset of 1.3 B, current valuation of 10.9 M, and EBITDA of 28.56 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend acquiring undervalued stocks and dropping overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Ligand Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of Ligand Pharmaceuticals is based on 3 months time horizon. Increasing Ligand Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Ligand Pharmaceuticals Tr is useful when determining the fair value of the Ligand pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Ligand Pharmaceuticals. Since Ligand Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ligand Pink Sheet. However, Ligand Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.11 | Real 0.1 | Hype 0.11 | Naive 0.1 |
The real value of Ligand Pink Sheet, also known as its intrinsic value, is the underlying worth of Ligand Pharmaceuticals Company, which is reflected in its stock price. It is based on Ligand Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Ligand Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ligand Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ligand Pharmaceuticals Tr helps investors to forecast how Ligand pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ligand Pharmaceuticals more accurately as focusing exclusively on Ligand Pharmaceuticals' fundamentals will not take into account other important factors: Ligand Pharmaceuticals Total Value Analysis
Ligand Pharmaceuticals Tr is now forecasted to have takeover price of 10.9 M with market capitalization of 10.9 M, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ligand Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
| 10.9 M | 10.9 M |
Ligand Pharmaceuticals Investor Information
The company had not issued any dividends in recent years. The quote for Ligand Pharmaceuticals Tr is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC.Ligand Pharmaceuticals Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Ligand suggests not a very effective usage of assets in April.Ligand Pharmaceuticals Profitability Analysis
The company reported the revenue of 277.13 M. Net Income was 629.3 M with profit before overhead, payroll, taxes, and interest of 0. Profitability |
| Values |
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ligand Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ligand Pharmaceuticals and how it compares across the competition.
About Ligand Pharmaceuticals Valuation
The pink sheet valuation mechanism determines the current worth of Ligand Pharmaceuticals Tr on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Ligand Pharmaceuticals Tr. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Ligand Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Ligand Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Ligand Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ligand Pharmaceuticals. We calculate exposure to Ligand Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ligand Pharmaceuticals's related companies.8 Steps to conduct Ligand Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ligand Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ligand Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ligand Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ligand Pharmaceuticals' revenue streams: Identify Ligand Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ligand Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ligand Pharmaceuticals' growth potential: Evaluate Ligand Pharmaceuticals' management, business model, and growth potential.
- Determine Ligand Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ligand Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Ligand Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Ligand Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 33.8 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Ligand Pharmaceuticals information on this page should be used as a complementary analysis to other Ligand Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Ligand Pink Sheet analysis
When running Ligand Pharmaceuticals' price analysis, check to measure Ligand Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ligand Pharmaceuticals is operating at the current time. Most of Ligand Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ligand Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ligand Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ligand Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |